BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Diagnosis
36 results:

  • 1. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
    Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Kapoor A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
    Urol Oncol; 2023 Feb; 41(2):110.e7-110.e14. PubMed ID: 36456452
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
    Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
    Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
    Bell PD; Huber AR; Agostini-Vulaj D
    Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Impact of Cell-free Plasma DNA on Metastatic and Nonmetastatic prostate cancer.
    Abonar AA; Ayoub SE; Tagreda IA; Abdelhafez MN; Khamiss MM; Abdelaziz MI; Gaber SN; Amin A; Mohammed SR
    Curr Mol Med; 2022; 22(1):67-73. PubMed ID: 33632098
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multiparametric MRI in the diagnosis of prostate cancer: Physical Foundations, Limitations, and Prospective Advances of Diffusion-Weighted MRI.
    Wichtmann BD; Zöllner FG; Attenberger UI; Schönberg SO
    Rofo; 2021 Apr; 193(4):399-409. PubMed ID: 33302312
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Telepathology Practice in cancer diagnosis in Saint Jean de Dieu Hospital - Tanguieta, Benin.
    Azakpa AL; Priuli FF; Ndayake E; Ganhouingnon E; Gonzalez-Rodilla I; Tchaou MP; Zanin T
    Arch Pathol Lab Med; 2021 Jul; 145(7):871-876. PubMed ID: 33091927
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against ttf-1 and Diagnostic Implications.
    Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S
    Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].
    Cowppli-Bony A; Colonna M; Ligier K; Jooste V; Defossez G; Monnereau A; ;
    Bull Cancer; 2019; 106(7-8):617-634. PubMed ID: 30833045
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Oncocytic poorly differentiated (insular) thyroid carcinoma mimicking metastatic adenocarcinoma. A case report and review of the literature.
    Laforga JB; Cortés VA
    Diagn Cytopathol; 2019 Jun; 47(6):584-588. PubMed ID: 30637975
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cystic metastasis of prostate cancer: A case report.
    Zhang B; Bian B; Bi L; Wang Z; Zhao Y; Wang J
    Medicine (Baltimore); 2018 Dec; 97(50):e13697. PubMed ID: 30558081
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA).
    Carles J; Pichler A; Korunkova H; Tomova A; Ghosn M; El Karak F; Makdessi J; Koroleva I; Barnes G; Bury D; Özatilgan A; Hitier S; Katolicka J
    BJU Int; 2019 Mar; 123(3):456-464. PubMed ID: 30098093
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [A Case of Synchronous Quadruple cancers Treated with Neoadjuvant Chemotherapy Followed by Surgery].
    Muramoto K; Miyake T; Shimizu T; Sonoda H; Ueki T; Terada Y; Mori H; Maehira H; Takebayashi K; Kaida S; Iida H; Yamaguchi T; Tani M
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1871-1873. PubMed ID: 29394804
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent prostate cancer.
    Loi M; Di Cataldo V; Simontacchi G; Detti B; Bonomo P; Masi L; Desideri I; Greto D; Francolini G; Carfora V; Pezzulla D; Perna M; Carta GA; Livi L
    Clin Oncol (R Coll Radiol); 2018 Feb; 30(2):93-100. PubMed ID: 29208480
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Relation of Coronary Artery Calcium Score and Risk of cancer (from a Danish Population-Based Follow-up Study in Patients Who Underwent Cardiac Computed Tomography).
    Vinter N; Christesen AMS; Mortensen LS; Lindholt JS; Johnsen SP; Tjønneland A; Frost L
    Am J Cardiol; 2017 Aug; 120(4):542-549. PubMed ID: 28645476
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancer.
    Paoluzzi M; Losa A; Cerboneschi V; Colosimo C; Fontana N; Mangili P; Mignogna M; Nava L; Ravaglia V
    Brachytherapy; 2017; 16(5):1000-1006. PubMed ID: 28642046
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias.
    Kaye JA; Margulis AV; Fortuny J; McQuay LJ; Plana E; Bartsch JL; Bui CL; Perez-Gutthann S; Arana A
    Pharmacotherapy; 2017 Jun; 37(6):673-683. PubMed ID: 28370075
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [prostate Carcinoma Mimics Lung Carcinoma: A Case Report].
    Drosos K; Höfner K
    Aktuelle Urol; 2017 Apr; 48(2):153-155. PubMed ID: 28081573
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.
    Matthew EM; Zhou L; Yang Z; Dicker DT; Holder SL; Lim B; Harouaka R; Zheng SY; Drabick JJ; Lamparella NE; Truica CI; El-Deiry WS
    Oncotarget; 2016 Jan; 7(4):3662-76. PubMed ID: 26695546
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Update of the results of the Spanish branch of the European Randomized Study on Screening for prostate cancer (ERSPC).
    Luján M; Páez Á; Angulo JC; Andrés G; Gimbernat H; Redondo C; Torres GM; Berenguer A
    Actas Urol Esp; 2015 Sep; 39(7):405-13. PubMed ID: 25777669
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Olfactory system of highly trained dogs detects prostate cancer in urine samples.
    Taverna G; Tidu L; Grizzi F; Torri V; Mandressi A; Sardella P; La Torre G; Cocciolone G; Seveso M; Giusti G; Hurle R; Santoro A; Graziotti P
    J Urol; 2015 Apr; 193(4):1382-7. PubMed ID: 25264338
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.